Search results
Greater Noida Authority launches builder plots scheme for 8,000 flats. Here are 5 things to know
CNBC Awaaz· 4 days agoThe Greater Noida Industrial Development Authority (GNIDA) has cleared the way for building more...
Mutual fund investors ease off buying pedal as FPIs make comeback
Business Standard India· 6 days agoMutual funds’ (MFs’) equity buying hit a four-month low in June at Rs 20,359 crore as stocks...
Moneycontrol Daily: Your Essential 7
CNBC Awaaz· 5 days agoA daily round-up of the most interesting articles to help jump-start the day.
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors - ET HealthWorld |...
The Economic Times· 4 days agoEmcure Pharma: The pharma firm has decided to allot 57.8 lakh equity shares to 48 funds at Rs 1,008...
AMFI releases new stock categorization, cut-offs for largecap hiked to Rs 84,000 crore - The...
The Economic Times· 2 days agoThe Association of Mutual Funds in India (AMFI) on Thursday has officially released the market cap...
Budget 2024: Top Equity, Mutual and Thematic Funds to Invest in for Bumper Gains; Expert Recommends...
Times Now· 1 day agoThis optimism is fueled by the stable, growth-oriented policies of the current government, led by...
RBI keeps floating rate savings bond interest rate for July-Dec at 8.05%
Business Standard India· 5 days agoThe Reserve Bank of India (RBI) has said the interest rate for its Floating Rate Savings Bonds 2020...
Bain Capital-backed Emcure Pharma mobilises Rs 583 cr from anchor investors
The Economic Times· 5 days agoEmcure Pharmaceuticals has allocated 57.8 lakh equity shares to 48 funds at the upper end of the IPO...
This stock has rallied 31% in 4 days on fund buying; up 237% in 1 year
Business Standard India· 6 days agoSharda Motor hit a new high of Rs 2,618.80, surging 19% on the NSE in intra-day trade; has zoomed...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 3 days agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...